Improving the monitoring of Kaposi sarcoma treatment using advanced imaging technology.
Official title: PRecision IMaging to Evaluate Kaposi Sarcoma (PRIME-KS)
Funded at Washington University · NIH-10951388 · Data updated 2026-11-12
This study is testing a new tool called SkinScan3D to help doctors better track how well treatments are working for people with Kaposi sarcoma, especially in places where healthcare can be challenging, so patients can get the best care possible.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | August 7, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $576,630 |
| NIH project number | 1U01CA292765-01 |
| Project ID | NIH-10951388 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Kaposi sarcoma, particularly those receiving treatment in low- and middle-income countries.
✕Less likely to help
Patients who do not have Kaposi sarcoma or those receiving treatment in high-income countries may not benefit from this research.
What this research studies
This research focuses on enhancing the monitoring of treatment responses for Kaposi sarcoma (KS) through the use of a new technology called SkinScan3D (SS3D). The current methods for assessing KS lesions are often subjective and can lead to prolonged treatment and unnecessary side effects, especially in low- and middle-income countries. By implementing SS3D, which utilizes liquid lens technology and artificial intelligence, the research aims to provide a more objective and efficient way to monitor KS lesions, ultimately improving patient care in regions where it is most needed.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely monitoring of Kaposi sarcoma treatment, reducing unnecessary side effects and improving patient outcomes.
How similar studies have gone: Other research has shown promise in using advanced imaging technologies for cancer monitoring, suggesting that this approach could be effective.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Odeny, Thomas — Washington University
- Study coordinator: Odeny, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Precision 3D Imaging to Monitor Kaposi Sarcoma (KS) with SkinScan3D
A new portable 3D imaging tool called SkinScan3D will help doctors measure KS skin lesions more accurately and quickly, especially in people living with HIV.
-
Precision 3D Imaging to Track Kaposi Sarcoma (KS) with SkinScan3D
A new 3D imaging tool called SkinScan3D helps doctors monitor Kaposi sarcoma lesions more accurately and quickly, especially in settings with high KS burden like East Africa and in U.S. clinics with HIV patients.
-
Kaposi Sarcoma care and research in Africa during ART era
A collaborative program to better understand and improve diagnosis, treatment, and prevention of Kaposi sarcoma for people living with HIV in Zambia and Tanzania.
-
Kaposi Sarcoma in Africa: ART Era Research Network
A collaborative program in Africa and the United States will study Kaposi sarcoma in people living with HIV on ART to improve diagnosis, treatment, and prevention.
-
Kaposi Sarcoma in Africa in the ART Era
This grant supports research to improve how Kaposi sarcoma is detected, treated, and understood in people living with HIV in Zambia and Tanzania during ART, with collaboration between African hospitals and a U.S. center.
-
Faster detection and connection to care for people with HIV who develop Kaposi sarcoma in East Africa
This project aims to speed up finding people with HIV diagnosed with Kaposi sarcoma in East Africa and help them get linked to care more quickly.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.